ETFs
R
RPRX
Royalty Pharma Plc
60.96
+1.34+2.25%After Hours: 60.96 0.00 0.00%19:30 10/16 EDT
OPEN/PREV CLOSE63.50/63.75
TODAY RANGE63.01-63.97
VOL4.02M
MARKET CAP36.72B
52 WEEK RANGE35.23-64.38
AVG VOL (3M)3.00M
% TURNOVER0.50%
TURNOVER--
P/E (TTM)34.00
% RANGE1.51%
EPS(TTM)1.878
P/E(FORWARD)25.99
P/B5.38
BVPS11.87
DIVIDEND0.9400
P/S15.50
BETA--
DIV YIELD1.47%
FREE FLOAT MKT CAP26.58B
SHARES OUTSTANDING575.00M
NEXT EARNINGS11/03-11/09
FREE FLOAT416.22M
LOT SIZE1
EX-DATE11/13/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·10h ago
BeOne Medicines: Brukinsa And Tevimbra Face A High Bar
The Motley Fool·1d ago
3 Reasons Royalty Pharma Is a Dividend Stock You Never Have to Sell
Seeking Alpha·5d ago
Goldman's defensive stocks with quality-growth characteristics
Seeking Alpha·10/16 16:19
Royalty Pharma declares $0.235 dividend
Dow Jones·10/16 12:00
Press Release: Royalty Pharma declares fourth quarter 2026 dividend
Benzinga·10/15 15:45
If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today
Simply Wall St·10/12 19:30
Royalty Pharma (RPRX), Why Is It Back In The Spotlight?
TipRanks·10/12 11:46
Royalty Pharma (RPRX) Gets a Buy from Citi
TipRanks·10/09 12:17
Bank of America Securities Remains a Buy on Royalty Pharma (RPRX)
NASDAQ·10/08 15:10
Why Royalty Pharma (RPRX) is Poised to Beat Earnings Estimates Again
Dow Jones·10/07 15:06
Royalty Pharma Is Maintained at Overweight by Morgan Stanley
TipRanks·10/07 12:26
Royalty Pharma (RPRX) Gets a Buy from Morgan Stanley
Seeking Alpha·10/03 13:34
Revolution Medicines: Priced For A Label The Trial Didn't Test; Hold
The Motley Fool·10/01 16:50
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?
Same Industry
Name/Symbol
Change%
Price